Memantine Hcl



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Dementia Alzheimer's Type 68.2%
Dementia 11.8%
Hypertension 3.2%
Drug Use For Unknown Indication 2.5%
Depression 2.0%
Constipation 1.6%
Abnormal Behaviour 1.1%
Cognitive Disorder 1.0%
Pain 1.0%
Agitation 0.9%
Epilepsy 0.9%
Insomnia 0.8%
Intentional Overdose 0.8%
Anxiety 0.7%
Apathy 0.7%
Cerebral Infarction 0.6%
Dementia With Lewy Bodies 0.6%
Parkinson's Disease 0.6%
Vascular Dementia 0.6%
Diabetes Mellitus 0.5%
Somnolence 10.4%
Vomiting 9.6%
White Blood Cell Count Increased 7.0%
Urinary Tract Infection 6.7%
Death 6.4%
Weight Decreased 6.1%
Pancreatitis 5.8%
Tremor 5.2%
Syncope 4.9%
Epilepsy 4.3%
Pyrexia 4.3%
Pneumonia 4.1%
Fall 3.8%
Pancreatitis Acute 3.8%
Renal Impairment 3.2%
Restlessness 3.2%
Cardiac Failure 2.9%
General Physical Health Deterioration 2.9%
Sinus Bradycardia 2.9%
Jaundice 2.6%
Secondary
Dementia Alzheimer's Type 50.0%
Product Used For Unknown Indication 7.8%
Dementia 7.3%
Drug Use For Unknown Indication 5.9%
Hypertension 4.9%
Pain 4.6%
Complex Regional Pain Syndrome 2.1%
Neuralgia 2.1%
Hallucination 2.0%
Depression 1.9%
Abnormal Behaviour 1.7%
Cerebral Infarction 1.4%
Cognitive Disorder 1.2%
Constipation 1.2%
Nausea 1.2%
Blood Pressure 1.1%
Behavioural And Psychiatric Symptoms Of Dementia 1.0%
Anxiety 0.9%
Diabetes Mellitus 0.9%
Gastritis 0.9%
Somnolence 14.0%
Pneumonia 9.1%
Death 7.0%
Altered State Of Consciousness 5.8%
Renal Failure Acute 5.8%
Gait Disturbance 5.0%
Off Label Use 5.0%
Urinary Tract Infection 4.5%
Pancreatitis Acute 4.1%
Syncope 4.1%
Tremor 4.1%
Hemiplegia 3.7%
Malaise 3.7%
Pyrexia 3.7%
Sinus Bradycardia 3.7%
Condition Aggravated 3.3%
Fall 3.3%
Grand Mal Convulsion 3.3%
Pre-existing Condition Improved 3.3%
Sputum Increased 3.3%
Concomitant
Drug Use For Unknown Indication 25.9%
Dementia Alzheimer's Type 15.5%
Product Used For Unknown Indication 10.3%
Dementia 9.0%
Hypertension 8.9%
Depression 5.7%
Diabetes Mellitus 2.4%
Pain 2.4%
Parkinson's Disease 2.4%
Agitation 2.1%
Insomnia 1.8%
Memory Impairment 1.8%
Osteoporosis 1.8%
Unevaluable Event 1.8%
Atrial Fibrillation 1.6%
Acquired Immunodeficiency Syndrome 1.3%
Cardiac Disorder 1.3%
Urinary Tract Infection 1.3%
Nervous System Disorder 1.2%
Prophylaxis 1.2%
Vomiting 12.5%
Somnolence 11.3%
Urinary Tract Infection 10.7%
Weight Decreased 6.5%
Fall 6.0%
Pyrexia 4.8%
Syncope 4.8%
Hypoglycaemia 4.2%
Loss Of Consciousness 4.2%
Renal Failure 4.2%
Unevaluable Event 4.2%
Death 3.6%
Toxic Skin Eruption 3.6%
Dementia 3.0%
Rectal Haemorrhage 3.0%
Tachycardia 3.0%
Thrombocytopenia 3.0%
Traumatic Haematoma 3.0%
Acute Myocardial Infarction 2.4%
Pulmonary Embolism 2.4%
Interacting
Dementia Alzheimer's Type 28.6%
Gastrooesophageal Reflux Disease 9.5%
Prophylaxis Urinary Tract Infection 9.5%
Restless Legs Syndrome 9.5%
Citrobacter Infection 7.1%
Delirium 7.1%
Atrial Fibrillation 4.8%
Dementia 4.8%
Hypertension 4.8%
Transient Ischaemic Attack 4.8%
Amnesia 2.4%
Arthralgia 2.4%
Bipolar Disorder 2.4%
Urinary Tract Infection 2.4%
Myoclonus 33.3%
Drug Interaction 16.7%
Rectal Haemorrhage 16.7%
Retroperitoneal Haematoma 8.3%
Somnolence 8.3%
Syncope 8.3%
Syncope Vasovagal 8.3%